Dr. Agarwal's Health Care sets July 2 merger meeting
June 01, 2026
Dr. Agarwal's Health Care Limited has announced July 2, 2026, meetings for shareholders and creditors to approve the merger with Dr. Agarwal's Eye Hospital Limited. The physical meetings, ordered by the NCLT Chennai Bench, will be held in Chennai, with e-voting open from June 7 to July 1.
Dr. Agarwal's Health Care Limited has dispatched physical notices to equity shareholders and creditors to convene meetings on July 2, 2026, for approving the proposed amalgamation with Dr. Agarwal's Eye Hospital Limited. The meetings, directed by the Hon'ble National Company Law Tribunal, Chennai Bench, will consider the scheme of amalgamation under Sections 230 to 232 of the Companies Act, 2013. The company has provided web-links and QR codes to stakeholders whose email addresses are not registered to access the notices and relevant documents.
The meeting for equity shareholders is scheduled at 12:30 P.M. (IST), while the meeting for unsecured creditors will follow at 4:00 P.M. (IST). Both gatherings will be conducted in non-virtual, physical mode at The Music Academy, T.T.K. Road, Chennai. The notices were sent electronically to registered stakeholders, while physical letters were dispatched to those without valid email records.
Meeting and Voting Schedule
Key dates for the equity shareholders' meeting include a cut-off date of May 22, 2026, for sending notices and June 3, 2026, for determining e-voting eligibility. For unsecured creditors, the cut-off date for eligibility is December 31, 2025. Remote e-voting for both groups opens on June 7, 2026, at 9:00 A.M. (IST) and closes on July 1, 2026, at 5:00 P.M. (IST).
Event Date and Time Details Equity Shareholders Meeting July 02, 2026 at 12:30 P.M. (IST) The Music Academy, Chennai Unsecured Creditors Meeting July 02, 2026 at 04:00 P.M. (IST) The Music Academy, Chennai Remote e-Voting Start June 07, 2026 at 9:00 A.M. (IST) Electronic voting facility Remote e-Voting End July 01, 2026 at 5:00 P.M. (IST) Electronic voting facility Shareholder Cut-off Date May 22, 2026 Notice dispatch eligibility Creditor Cut-off Date December 31, 2025 E-voting eligibility
Access to Documents
The notice, explanatory statement, and annexures are available on the company's website and the stock exchanges where Dr. Agarwal's Health Care Limited is listed, including BSE Limited and National Stock Exchange of India Limited. Shareholders and creditors retain the right to request a physical copy of the notice free of cost by contacting the company at secretarial@dragarwal.com . Thanikainathan Arumugam, Company Secretary and Compliance Officer, signed the disclosures on June 1, 2026.
Dr. Agarwal's Health Care reported a robust financial performance for the year ended March 31, 2026, with Profit After Tax (PAT) growing 52.4% year-on-year to INR 168 Crores. The company achieved a significant operational milestone, with Revenue from Operations increasing 21.6% to INR 2,080 Crores, crossing the INR 2,000 Crore mark for the first time. EBITDA for the period rose 22.2% to INR 614 Crores, with margins expanding to 28.9%. Following the announcement, the company has made the audio recording of its analyst and earnings conference call held on May 21, 2026, available on its website.
Annual Financial Performance
The audited consolidated financial results highlight strong growth across key metrics. Total Income for the year stood at INR 2,125 Crores, a 20.9% increase compared to the previous year. The company maintained its operational efficiency, with EBITDA margins improving slightly from 28.6% in FY25 to 28.9% in FY26. Net profit margins also saw a significant rise, reaching 7.9% for the year.
Metric (INR Crores) Year Ended Mar 31, 2026 Year Ended Mar 31, 2025 YoY Growth Total Income 2,125 1,757 20.9% Revenue from Operations 2,080 1,711 21.6% EBITDA 614 502 22.2% Profit After Tax 168 110 52.4%
Operational Expansion
During FY26, the company expanded its network significantly, adding 57 new centers to take its total facility count to 288 across 10 countries. This included 30 surgical centers, strengthening clinical capacity. The company performed 323,245 surgeries during the year, reflecting a 14.5% growth in patient volumes. The entry into the Delhi NCR region was a key highlight, with six facilities becoming operational within twelve months.
Q4 Performance Highlights
For the quarter ended March 31, 2026, the company reported a Revenue from Operations of INR 564 Crores, up 22.6% year-on-year. Net profit for the quarter stood at INR 50 Crores, growing 17.4% YoY. EBITDA for Q4 FY26 was INR 174 Crores, with margins at 30.2%. The company added 19 new centers during the quarter alone, comprising 7 secondary and 12 primary facilities.
We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.
Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.
We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.
Disclaimer:
The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.
This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.
The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.
We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.
This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.
By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.
We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.
The meeting for equity shareholders is scheduled at 12:30 P.M. (IST), while the meeting for unsecured creditors will follow at 4:00 P.M. (IST). Both gatherings will be conducted in non-virtual, physical mode at The Music Academy, T.T.K. Road, Chennai. The notices were sent electronically to registered stakeholders, while physical letters were dispatched to those without valid email records.
Meeting and Voting Schedule
Key dates for the equity shareholders' meeting include a cut-off date of May 22, 2026, for sending notices and June 3, 2026, for determining e-voting eligibility. For unsecured creditors, the cut-off date for eligibility is December 31, 2025. Remote e-voting for both groups opens on June 7, 2026, at 9:00 A.M. (IST) and closes on July 1, 2026, at 5:00 P.M. (IST).
Event Date and Time Details Equity Shareholders Meeting July 02, 2026 at 12:30 P.M. (IST) The Music Academy, Chennai Unsecured Creditors Meeting July 02, 2026 at 04:00 P.M. (IST) The Music Academy, Chennai Remote e-Voting Start June 07, 2026 at 9:00 A.M. (IST) Electronic voting facility Remote e-Voting End July 01, 2026 at 5:00 P.M. (IST) Electronic voting facility Shareholder Cut-off Date May 22, 2026 Notice dispatch eligibility Creditor Cut-off Date December 31, 2025 E-voting eligibility
Access to Documents
The notice, explanatory statement, and annexures are available on the company's website and the stock exchanges where Dr. Agarwal's Health Care Limited is listed, including BSE Limited and National Stock Exchange of India Limited. Shareholders and creditors retain the right to request a physical copy of the notice free of cost by contacting the company at secretarial@dragarwal.com . Thanikainathan Arumugam, Company Secretary and Compliance Officer, signed the disclosures on June 1, 2026.
Dr. Agarwal's Health Care reported a robust financial performance for the year ended March 31, 2026, with Profit After Tax (PAT) growing 52.4% year-on-year to INR 168 Crores. The company achieved a significant operational milestone, with Revenue from Operations increasing 21.6% to INR 2,080 Crores, crossing the INR 2,000 Crore mark for the first time. EBITDA for the period rose 22.2% to INR 614 Crores, with margins expanding to 28.9%. Following the announcement, the company has made the audio recording of its analyst and earnings conference call held on May 21, 2026, available on its website.
Annual Financial Performance
The audited consolidated financial results highlight strong growth across key metrics. Total Income for the year stood at INR 2,125 Crores, a 20.9% increase compared to the previous year. The company maintained its operational efficiency, with EBITDA margins improving slightly from 28.6% in FY25 to 28.9% in FY26. Net profit margins also saw a significant rise, reaching 7.9% for the year.
Metric (INR Crores) Year Ended Mar 31, 2026 Year Ended Mar 31, 2025 YoY Growth Total Income 2,125 1,757 20.9% Revenue from Operations 2,080 1,711 21.6% EBITDA 614 502 22.2% Profit After Tax 168 110 52.4%
Operational Expansion
During FY26, the company expanded its network significantly, adding 57 new centers to take its total facility count to 288 across 10 countries. This included 30 surgical centers, strengthening clinical capacity. The company performed 323,245 surgeries during the year, reflecting a 14.5% growth in patient volumes. The entry into the Delhi NCR region was a key highlight, with six facilities becoming operational within twelve months.
Q4 Performance Highlights
For the quarter ended March 31, 2026, the company reported a Revenue from Operations of INR 564 Crores, up 22.6% year-on-year. Net profit for the quarter stood at INR 50 Crores, growing 17.4% YoY. EBITDA for Q4 FY26 was INR 174 Crores, with margins at 30.2%. The company added 19 new centers during the quarter alone, comprising 7 secondary and 12 primary facilities.
We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.
Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.
We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.
Disclaimer:
The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.
This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.
The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.
We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.
This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.
By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.
We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.